Sanofi Board Removes CEO Paul Hudson Effective Feb. 12, 2026
Sanofi’s board removed CEO Paul Hudson effective February 12, 2026, ending his tenure at the healthcare giant. The board has initiated a search for a permanent successor to oversee its strategic operations pending interim leadership.
1. Board Removes CEO Paul Hudson
On February 12, 2026, Sanofi’s board voted to remove CEO Paul Hudson effective immediately, concluding his tenure leading the company. The board has launched a formal succession process to identify a permanent replacement and ensure continuity of strategic initiatives pending an interim leadership structure.
Related News
TNL
Travel + Leisure Co. Declares $0.60 Per Share Cash Dividend Payable June 30
TNL•
GOOG
OpenAI Eyes Fall IPO After Lawsuit Win, Battling $900B Anthropic Rival
GOOG•
NVDA
Nvidia Projects $20 Billion in CPU Sales Within $200 Billion Market
NVDA•
ELF
e.l.f. Beauty Marks 29th Consecutive Sales Growth, Reinvests $58.5M Tariff Refunds
ELF•
ELF
Elf Beauty Q4 Sales Jump 35% to $449.3M, Forecasts Lower FY27 Sales
ELF•
Sources
F